| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
JD.Com Inc’s (NASDAQ:JD) healthcare subsidiary JD Health International Inc could be valued between $25.3 billion and $28.5 billion in its Hong Kong initial public offering, Bloomberg reports.
What Happened: With approximately 381.9 million share issues in a price range of HKD 62.8 and HKD 70.58, the Hong Kong listing is expected to generate between $3 billion and $3.5 billion in proceeds.
The pricing details could be out on Dec. 1 with the trading debut commencing a week later on Dec. 8.
Singapore Sovereign Wealth Fund GIC Pte Ltd., Hillhouse Capital Advisors Limited, BlackRock Inc (NYSE:BLK), and three other investors have agreed to subscribe for close to $1.35 billion worth of JD Health’s stock, as per Bloomberg.
Why Does It Matter: JD Health is on track to set a record for the largest healthcare sector IPO in Asia. It could overtake Japanese pharma company Otsuka Holdings Co (OTC:OTSKY), which has held the record for almost a decade with its $2.3 billion IPO in 2010.
In June, parent company JD.com too opted for a secondary listing, which turned out to be Hong Kong’s largest first-time shares sale of 2020.
Price Action: JD shares closed at $89.82, 2.58% higher, on Tuesday.
